Thus, it indicates a positive correlation between airway inflammation and CFTR modulator-induced lung function improvements and further establishes that inflammation is a key regulator of HCO3− secretion in CF airways and that it enhances the efficacy of CFTR modulators. This evidence concerns the gene CFTR and cystic fibrosis.